Schedule 13D ownership disclosure

Q32 BIO INC

Security class unavailable · CUSIP: 746964105

Event date: 2024-03-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
864,261
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-042096
Form type
SC 13D
Filer
Atlas Venture Fund X, L.P.
CIK
CIK 1628098
Filed
Apr 01, 2024
Reporting period
Mar 25, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub